-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Hold on IGM Biosciences, Lowers Price Target to $1

Benzinga·06/11/2025 17:33:39
Listen to the news
Truist Securities analyst Asthika Goonewardene maintains IGM Biosciences (NASDAQ:IGMS) with a Hold and lowers the price target from $2 to $1.